相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Irinotecan-Induced Mucositis Is Associated with Goblet Cell Dysregulation and Neural Cell Damage in a Tumour Bearing DA Rat Model
Daniel Thorpe et al.
PATHOLOGY & ONCOLOGY RESEARCH (2020)
Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties
Thaise Boeing et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Advances in the physiology of gastric emptying
Raj K. Goyal et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2019)
Flavonoid-rich fraction of Bauhinia forficata Link leaves prevents the intestinal toxic effects of irinotecan chemotherapy in IEC-6 cells and in mice
Camile Cecconi Cechinel-Zanchett et al.
PHYTOTHERAPY RESEARCH (2019)
Animal models of chemotherapy-induced mucositis: translational relevance and challenges
Per T. Sangild et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2018)
Role of regulatory T cells in irinotecan-induced intestinal mucositis
Camila Fernandes et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
From the Bottom-Up: Chemotherapy and Gut-Brain Axis Dysregulation
Juliana E. Bajic et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2018)
Carvacryl acetate, a novel semisynthetic monoterpene ester, binds to the TRPA1 receptor and is effective in attenuating irinotecan-induced intestinal mucositis in mice
Elenice M. Alvarenga et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2017)
Intestinal Epithelial and Intraepithelial T Cell Crosstalk Mediates a Dynamic Response to Infection
David P. Hoytema van Konijnenburg et al.
CELL (2017)
Irinotecan-Induced Gastrointestinal Dysfunction and Pain Are Mediated by Common TLR4-Dependent Mechanisms
Hannah R. Wardill et al.
MOLECULAR CANCER THERAPEUTICS (2016)
The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan
Raquel Duque Nascimento Arifa et al.
PHARMACOLOGICAL RESEARCH (2016)
Irinotecan (CPT-11)-induced elevation of bile acids potentiates suppression of IL-10 expression
Zhong-Ze Fang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Dark Agouti rat model of chemotherapy-induced mucositis: Establishment and current state of the art
Barbara Vanhoecke et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2015)
Irinotecan, a key chemotherapeutic drug for metastatic colorectal cancer
Ken-ichi Fujita et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
Guidance on the management of diarrhoea during cancer chemotherapy
Jervoise Andreyev et al.
LANCET ONCOLOGY (2014)
The light and dark sides of intestinal intraepithelial lymphocytes
Hilde Cheroutre et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile
Andrea M. Stringer et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
Richard M. Logan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer
RJ Gibson et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
分享论文
